NDC 50090-0295-01 - KENALOG-10
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0295
- Requested NDC
- 50090-0295-01
- Package NDCs from labels
- 50090-0295-1, 50090-0295-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| KENALOG-10 - A-S Medication Solutions | A-S Medication Solutions | 2026-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-03-17 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-03-17 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-01-30 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
| 2023-01-30 | KENALOG ® -10 INJECTION (triamcinolone acetonide injectable suspension, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0295-1 | KENALOG-10 | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 18 | |
| 50090-0295-1 | KENALOG-10 | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 5 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0295 | KENALOG-10 (TRIAMCINOLONE ACETONIDE) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS] | 18 | Current NDC, Legacy NDC, 2 package rows | 20230318_653ec195-0966-478d-be47-6b1ff158e111.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0295-1 | ML - Milliliter | 50090-0295 | bf8017ef-4e4e-49c0-9383-71e04e84cf4a | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| KENALOG-10 | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 653ec195-0966-478d-be47-6b1ff158e111 | 2026-07-30 | Warnings, Adverse reactions | NDA012041 50090-0295-1 50090-0295 50090029501 1085750 1085752 c31f11c2-b581-4f75-b0b4-9b97e80ff68e 653ec195-0966-478d-be47-6b1ff158e111 F446C597KA |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | CVS Pharmacy | 49003aac-184c-ae33-e063-6294a90a29c0 | 2026-07-24 | Warnings | LKG8494WBH |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H K679OBS311 |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Nitrogen | NITROGEN | Linde Inc. | 11f1ea16-93eb-4994-ba96-d0d7519015e2 | 2026-07-16 | N762921K75 | |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 3d495acf-8085-4aaa-8fc5-594b88c25c21 | 2026-07-13 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | 20c1234b-6749-422d-9420-9d5a98f5f30a | 2026-07-13 | Adverse reactions | F446C597KA |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Ascend Laboratories, LLC | ccca8660-124e-4220-8d87-4b9aeecbda7d | 2026-07-13 | Adverse reactions | F446C597KA |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Encube Ethicals, Inc. | db87426f-124c-4ea9-bb15-fc3a0da10a4e | 2026-07-07 | Adverse reactions | F446C597KA |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Encube Ethicals, Inc. | 6a31a0c3-2b6e-40e3-b5ea-5c665afd3567 | 2026-07-06 | Adverse reactions | F446C597KA |
| Retaine CMC | CARBOXYMETHYLCELLULOSE SODIUM | OCuSOFT LLC | a3698c71-0c80-4246-be52-5e7d96f6c540 | 2026-07-06 | Warnings | K679OBS311 |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.